Live Webinar

A Look at PBM Reform and Transparency: Payer, Provider and Patient Impact

Hosted by AJMC, Managed Healthcare Executive, Pharmacy Times and PBMI

-- Days : -- HRS : -- MIN : -- SEC
Register Now →
Evaluating Bimekizumab as a Treatment Option

Please see full Prescribing Information.

Presenter

Laura Coates, MBChB, MRCP, PhD

BIMZELX® is a registered trademark of
the UCB Group of Companies.
©2025 UCB, Inc., Smyrna, GA 30080.
All rights reserved.
US-BK-2500097 | January 2025